Minnesota Sen. Tina Smith won’t seek a second full term next year, opening up a seat in a Democratic-leaning state.
Maxim raised the firm’s price target on INmune Bio (INMB) to $30 from $22 and keeps a Buy rating on the shares. The company’s announcement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback